Safety and Tolerability Study of K0706 in Subjects With Parkinson's Disease

NCT02970019 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: K0706
DRUG: Placebo

Sponsor

Sun Pharma Advanced Research Company Limited